We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Xcounter | LSE:XCT | London | Ordinary Share | SE0000963100 | ORD NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 275.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMXCT
RNS Number : 3318J
XCounter AB
29 June 2011
XCounter
PRESS RELEASE
Stockholm, 29 June 2011
XCounter AB (publ)
Agreement Signed with Leading Healthcare Imaging Company
XCounter AB (publ) (AIM:XCT), a technology leader in the development and supply of specialty X-ray detectors and tomosynthesis based 3D medical imaging, is pleased to announce that it has signed an exclusive, worldwide agreement for the development and supply of photon counting digital X-ray detector technologies with a leading healthcare imaging company ("Partner"). Under the Agreement, it is intended that XCounter, which is headquartered in Stockholm, will develop and supply the Partner with high speed digital 3D X-ray imaging detectors based on its proprietary photon counting and solid-state material technologies.
Depending on the success of the R&D-project and assuming commencement of supply of detectors, the agreements have an aggregate value of up to EUR50m over the next nine years. As part of the Agreement but unconditional, XCounter has agreed to seek shareholder approval to grant a Warrant to the Partner by latest Dec 31, 2012 representing 12.5 per cent of XCounter shares at an exercise price equal to 3x the average closing price of XCounter's shares 30 days prior to this announcement. Further details to follow.
The Board now considers XCounter to be a going concern.
Mikael Strindlund, CEO of XCounter, commented, "This multi-year co-operation with a major, market-leading healthcare imaging company is clear evidence that XCounter is the technology leader within low dose high image quality providers of digital X-ray detectors. We look very much forward to a long and fruitful co-operation with our Partner."
For further information, please contact: XCounter AB Mikael Strindlund Tel: +46 (0) 8 622 23 00 Nomura Code Securities Limited Tel +44 (0) 20 7776 1200 Phil Walker/ Clare Terlouw Capital MSL Anna Davies Tel +44 207 307 5330 Justine Lamond
About XCounter AB
XCounter AB is a leader in the development of photon counting detector and tomosynthesis-based 3D x-ray imaging technology. It develops and manufactures high performance x-ray detector solutions based on state of the art technologies for applications in the medical, dental and industrial area.
In June 2010 XCounter completed the acquisition of Oy AJAT Ltd., a Finnish imaging company, complementing XCounter's photon counting and 3D imaging competence with CdTe detector development and production.
Headquartered in Stockholm, XCounter employs 28 people in its facilities in Sweden and Finland.
For more detailed information, please visit: www.xcounter.se
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGRPGUACQUPGUAB
1 Year Xcounter Chart |
1 Month Xcounter Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions